The compatibility of oxytocin and tranexamic acid injection products when mixed for co-administration by infusion for the treatment of postpartum haemorrhage: an in vitro investigation
Pete Lambert1, Alessandra Tomazzini2, Philip Wright1, Claire McEvoy1, Ioannis Gallos3, Anne Ammerdorffer2, Lester Chinery2, Arri Coomarasamy3, A. Metin Gülmezoglu2
1 Drug Delivery Disposition and Dynamics, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, VIC, 3052, Australia2 Concept Foundation, Bâtiment F2F3, Avenue de Sécheron 15, Geneva, 1202, Switzerland.3 Institute of Metabolism and Systems Research (IMSR), WHO Collaborating Centre for Global Women’s Health Research, University of Birmingham, Birmingham, UK
Corresponding author A. Metin Gülmezoglu, Concept Foundation, Bâtiment F2F3, Avenue de Sécheron 15, Geneva, 1202, Switzerland, gulmezoglum@conceptfoundation.org, +41 22 734 2560/1
Running title Oxytocin and tranexamic acid products mixed for co-administration